Replies to post #113815 on Progressive Care Inc (RXMD)

[TheSerb]

2017 Key Highlights
• Change of listing tier to OTCQB
• Addition of Independent Board Members: Jervis Hough and Oleg Firer
• Majority Independent Audit Committee
• Completion of 2016 Audited Financial Statements
• 225,000 prescriptions filled
• Over 21,000 prescriptions filled in a single month
• Over $20 million in net revenues
• Secured Community AIDS Network 340B contract.
• Doubled monthly 340B revenues since December 2016
• Raised over $2.75 million for 340B charitable organizations
• Reached over 50 employees
• Developed a tele-pharmacy platform in conjunction with software provider MDFlow
• Licensed in the following states: Colorado, Connecticut, Florida, Georgia, Illinois, Nevada, New Jersey, New York, Pennsylvania, Texas, Utah, Arizona, Massachusetts
• 5 star rating
• Opened first PharmCo Pharmacy Resource Center
• Celebrated PharmCo's 10 year anniversary

[TheSerb]

2018 Key Highlights
• Completion of 2017 Audited Financial Statements
• Secured first acquisition: PharmCo 1002 (Palm Beach County)
• Paid off all CVP notes
• Introduced Bitcoin and cryptocurrency functionality
• Launched Newly Designed Websites
• Launched New Prescription Platform
• Launched DischargeRx Program
• Launched Tele-PharmCo
• Launched 340B Backoffice Support
• Launched Program to Opioid Abuse
• LegitScript Certification
• Pilot Program: Westchester Hospital
• Over 300,000 prescriptions filled an increase of 35%
• Over 30,000 prescriptions filled in a single month
• Approx. $21 million in net revenues
• 5-star rating
• Top 20% Pharmacy in the nation
• Highest Humana Scores in Company history
• 4 active 340B contracts
• Increased 340B revenue by over 150%
• Processed over $6 million in claims on behalf of 340B entities
• Reached over 70 employees
• Licensed in the following states: Colorado, Connecticut, Florida, Georgia, Illinois, Nevada, New Jersey, New York, Pennsylvania,Texas, Utah, Arizona, Massachusetts, Minnesota
• New PR Partner: CMW Media
• New Investment Bank: The Benchmark Company
• FlyPharma Speaking Engagement
• Florida Tele-health Summit Speaking Engagement
• Contributed Articles published in prestigious industry trade magazines: Pharmacy Times, Pharmacy Business, World Pharma Today, Drug Topics, Authority
• Purchase PharmCo's first building: 400 Ansin Blvd

[TheSerb]

Outlook
The Company has never been more optimistic than it is beginning this year. 2019 will undoubtedly bring hardships, but this Company hasproven resilient and unfazed by headwinds no matter its cause. 2019 will be a year of tremendous transformation as we leap into our technological objectives. We intend to develop our own proprietary software for a number of applications that will greatly improve the way the healthcare industry interacts amongst itself and its patients. The platforms developed in 2018 will provide the base for further advancement, that will make the Company steps ahead of our competitors and create additional revenue opportunities.

We plan to begin development of our own line of CBD products to increase awareness of its therapeutic capabilities. We intend to provide patients with a brand of products that is easy to use, easy to understand, and meets the highest standards the industry has to offer. Putting our reputation behind the products we create will help patients feel comforted in the knowledge that a healthcare company stands behind the product they use for their well-being.

We expect to close on another acquisition. Growth through acquisition will improve our profitability, scale, geographical reach, and negotiating power with other organizations and insurance carriers. Upon execution of the acquisition currently underway, we hope to doublethe size we are today.

As always, we intend to continue to develop our core products and services, providing best in class solutions for medication therapy management, health consultations, compounding, long term care, post-discharge care, risk management, 340B, and adherence. Through further growth in these areas, we will increase same store prescriptions filled and revenues.

[TheSerb]

The following are our strategic goals for 2019:
• Achieve 40,000 prescriptions filled in a single month
• Increase annual same store sales to $24 million
• Close on second acquisition leading to consolidated revenue of over $35 million
• Secure additional 340B contracts and long-term care facility relationships
• Achieve accreditation for non-sterile compounding
• Achieve full enterprise profitability and earnings growth
• Install Tele-PharmCo enabled kiosks and equipment in senior living communities and large-scale clinics
• Develop exclusive line of CBD products
• Conduct PharmCo evidence-based case studies
• Release PharmCo's first televised advertisement
• Become SEC registered and fully reporting